nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—UGT2B7—Epirubicin—bone cancer	0.169	0.191	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—bone cancer	0.0895	0.101	CbGbCtD
Pitavastatin—ABCC2—Carboplatin—bone cancer	0.0826	0.0933	CbGbCtD
Pitavastatin—ABCG2—Carboplatin—bone cancer	0.0747	0.0843	CbGbCtD
Pitavastatin—ABCC2—Cisplatin—bone cancer	0.0706	0.0797	CbGbCtD
Pitavastatin—ABCG2—Cisplatin—bone cancer	0.0638	0.0721	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—bone cancer	0.0521	0.0589	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—bone cancer	0.0473	0.0534	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—bone cancer	0.0458	0.0517	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—bone cancer	0.0428	0.0483	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—bone cancer	0.0414	0.0468	CbGbCtD
Pitavastatin—ALB—Methotrexate—bone cancer	0.0286	0.0322	CbGbCtD
Pitavastatin—CYP2C9—Cisplatin—bone cancer	0.0237	0.0268	CbGbCtD
Pitavastatin—ABCB1—Cisplatin—bone cancer	0.023	0.026	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—bone cancer	0.0154	0.0174	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—bone cancer	0.0149	0.0169	CbGbCtD
Pitavastatin—SLC10A1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00514	0.0583	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.0034	0.0385	CbGpPWpGaD
Pitavastatin—UGT2B7—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.0031	0.0352	CbGpPWpGaD
Pitavastatin—SLC10A1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.003	0.0341	CbGpPWpGaD
Pitavastatin—SLC10A1—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00275	0.0312	CbGpPWpGaD
Pitavastatin—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00246	0.0279	CbGpPWpGaD
Pitavastatin—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00231	0.0262	CbGpPWpGaD
Pitavastatin—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0023	0.0261	CbGpPWpGaD
Pitavastatin—SLCO2B1—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.0022	0.025	CbGpPWpGaD
Pitavastatin—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00216	0.0245	CbGpPWpGaD
Pitavastatin—Memory loss—Cisplatin—bone cancer	0.00209	0.0969	CcSEcCtD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.002	0.0227	CbGpPWpGaD
Pitavastatin—UGT1A3—Estrogen metabolism—CYP3A4—bone cancer	0.00191	0.0216	CbGpPWpGaD
Pitavastatin—Rosuvastatin—CYP3A4—bone cancer	0.00186	0.398	CrCbGaD
Pitavastatin—UGT2B7—Estrogen metabolism—CYP3A4—bone cancer	0.00162	0.0184	CbGpPWpGaD
Pitavastatin—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.00157	0.0178	CbGpPWpGaD
Pitavastatin—UGT1A3—Metapathway biotransformation—CYP4V2—bone cancer	0.00156	0.0177	CbGpPWpGaD
Pitavastatin—Fluvastatin—CYP3A4—bone cancer	0.0015	0.322	CrCbGaD
Pitavastatin—SLCO1B1—Irinotecan Pathway—CYP3A4—bone cancer	0.00148	0.0167	CbGpPWpGaD
Pitavastatin—UGT2B7—Tamoxifen metabolism—CYP3A4—bone cancer	0.00143	0.0162	CbGpPWpGaD
Pitavastatin—ABCG2—Irinotecan Pathway—CYP3A4—bone cancer	0.00137	0.0155	CbGpPWpGaD
Pitavastatin—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00135	0.0153	CbGpPWpGaD
Pitavastatin—UGT2B7—Metapathway biotransformation—CYP4V2—bone cancer	0.00133	0.0151	CbGpPWpGaD
Pitavastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00132	0.015	CbGpPWpGaD
Pitavastatin—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00132	0.015	CbGpPWpGaD
Pitavastatin—Atorvastatin—CYP3A4—bone cancer	0.00131	0.28	CrCbGaD
Pitavastatin—Cognitive impairment—Methotrexate—bone cancer	0.00129	0.0599	CcSEcCtD
Pitavastatin—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00126	0.0143	CbGpPWpGaD
Pitavastatin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00126	0.0143	CbGpPWpGaD
Pitavastatin—UGT1A3—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.0012	0.0136	CbGpPWpGaD
Pitavastatin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00116	0.0131	CbGpPWpGaD
Pitavastatin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00108	0.0123	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00108	0.0123	CbGpPWpGaD
Pitavastatin—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00108	0.0122	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—FOLR1—bone cancer	0.00105	0.0119	CbGpPWpGaD
Pitavastatin—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00103	0.0117	CbGpPWpGaD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.000813	0.00921	CbGpPWpGaD
Pitavastatin—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000811	0.0092	CbGpPWpGaD
Pitavastatin—Cognitive disorder—Methotrexate—bone cancer	0.000779	0.0361	CcSEcCtD
Pitavastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000773	0.00876	CbGpPWpGaD
Pitavastatin—Myositis—Epirubicin—bone cancer	0.000643	0.0298	CcSEcCtD
Pitavastatin—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000638	0.00723	CbGpPWpGaD
Pitavastatin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000633	0.00717	CbGpPWpGaD
Pitavastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000622	0.00705	CbGpPWpGaD
Pitavastatin—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000613	0.00695	CbGpPWpGaD
Pitavastatin—Myositis—Doxorubicin—bone cancer	0.000595	0.0276	CcSEcCtD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000581	0.00659	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000569	0.00645	CbGpPWpGaD
Pitavastatin—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000519	0.00588	CbGpPWpGaD
Pitavastatin—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000499	0.00566	CbGpPWpGaD
Pitavastatin—Renal failure acute—Cisplatin—bone cancer	0.000482	0.0224	CcSEcCtD
Pitavastatin—Interstitial lung disease—Methotrexate—bone cancer	0.000476	0.0221	CcSEcCtD
Pitavastatin—Amnesia—Cisplatin—bone cancer	0.000474	0.022	CcSEcCtD
Pitavastatin—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000463	0.00525	CbGpPWpGaD
Pitavastatin—UGT1A3—Phase II conjugation—GSTP1—bone cancer	0.000458	0.00519	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000438	0.00496	CbGpPWpGaD
Pitavastatin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000431	0.00488	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000421	0.00477	CbGpPWpGaD
Pitavastatin—Nasopharyngitis—Cisplatin—bone cancer	0.000398	0.0185	CcSEcCtD
Pitavastatin—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.00039	0.00442	CbGpPWpGaD
Pitavastatin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000382	0.00432	CbGpPWpGaD
Pitavastatin—Abdominal discomfort—Cisplatin—bone cancer	0.000369	0.0171	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000365	0.00414	CbGpPWpGaD
Pitavastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000363	0.00412	CbGpPWpGaD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00036	0.00408	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000357	0.00404	CbGpPWpGaD
Pitavastatin—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000356	0.00404	CbGpPWpGaD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00034	0.00385	CbGpPWpGaD
Pitavastatin—UGT1A3—Biological oxidations—CYP3A4—bone cancer	0.000313	0.00355	CbGpPWpGaD
Pitavastatin—UGT1A3—Metapathway biotransformation—CYP3A4—bone cancer	0.000309	0.0035	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—GSTP1—bone cancer	0.000306	0.00346	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—TGFBR2—bone cancer	0.000306	0.00346	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000293	0.00332	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00029	0.00329	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—DHFR—bone cancer	0.000288	0.00326	CbGpPWpGaD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000283	0.00321	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—NDUFA12—bone cancer	0.000283	0.00321	CbGpPWpGaD
Pitavastatin—Hepatic failure—Methotrexate—bone cancer	0.000272	0.0126	CcSEcCtD
Pitavastatin—UGT1A3—Biological oxidations—GSTP1—bone cancer	0.000268	0.00304	CbGpPWpGaD
Pitavastatin—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000267	0.00302	CbGpPWpGaD
Pitavastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000265	0.003	CbGpPWpGaD
Pitavastatin—Renal failure acute—Methotrexate—bone cancer	0.000265	0.0123	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000265	0.003	CbGpPWpGaD
Pitavastatin—UGT1A3—Metapathway biotransformation—GSTP1—bone cancer	0.000264	0.003	CbGpPWpGaD
Pitavastatin—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000263	0.00298	CbGpPWpGaD
Pitavastatin—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000261	0.00296	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.00026	0.00295	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.00026	0.00295	CbGpPWpGaD
Pitavastatin—Muscle spasms—Cisplatin—bone cancer	0.000258	0.012	CcSEcCtD
Pitavastatin—Hepatic failure—Epirubicin—bone cancer	0.000255	0.0118	CcSEcCtD
Pitavastatin—ALB—Platelet degranulation—SPARC—bone cancer	0.000252	0.00286	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00025	0.00284	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Cisplatin—bone cancer	0.000249	0.0115	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—bone cancer	0.000248	0.0115	CcSEcCtD
Pitavastatin—Malaise—Cisplatin—bone cancer	0.000242	0.0112	CcSEcCtD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00024	0.00272	CbGpPWpGaD
Pitavastatin—Hepatic failure—Doxorubicin—bone cancer	0.000236	0.0109	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—NT5C3A—bone cancer	0.000234	0.00266	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000234	0.00265	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NDUFA12—bone cancer	0.000231	0.00261	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.00023	0.00261	CbGpPWpGaD
Pitavastatin—Renal failure acute—Doxorubicin—bone cancer	0.000229	0.0106	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—bone cancer	0.000229	0.0106	CcSEcCtD
Pitavastatin—Myalgia—Cisplatin—bone cancer	0.000228	0.0106	CcSEcCtD
Pitavastatin—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000228	0.00258	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000226	0.00257	CbGpPWpGaD
Pitavastatin—Discomfort—Cisplatin—bone cancer	0.000226	0.0105	CcSEcCtD
Pitavastatin—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000225	0.00255	CbGpPWpGaD
Pitavastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000216	0.00244	CbGpPWpGaD
Pitavastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000215	0.00243	CbGpPWpGaD
Pitavastatin—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000213	0.00241	CbGpPWpGaD
Pitavastatin—Pain in extremity—Doxorubicin—bone cancer	0.000212	0.00982	CcSEcCtD
Pitavastatin—HMGCR—AMPK Signaling—TP53—bone cancer	0.000211	0.00239	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000206	0.00234	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000206	0.00234	CbGpPWpGaD
Pitavastatin—Nasopharyngitis—Epirubicin—bone cancer	0.000205	0.00949	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—bone cancer	0.000203	0.0094	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000199	0.00925	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—bone cancer	0.000198	0.00917	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000196	0.00222	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000196	0.00222	CbGpPWpGaD
Pitavastatin—Erectile dysfunction—Methotrexate—bone cancer	0.000195	0.00903	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—NT5C3A—bone cancer	0.000191	0.00216	CbGpPWpGaD
Pitavastatin—Nasopharyngitis—Doxorubicin—bone cancer	0.000189	0.00878	CcSEcCtD
Pitavastatin—UGT1A3—Metabolism—NDUFA12—bone cancer	0.000188	0.00213	CbGpPWpGaD
Pitavastatin—Influenza—Doxorubicin—bone cancer	0.000183	0.00849	CcSEcCtD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.000182	0.00206	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Cisplatin—bone cancer	0.00018	0.00837	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—NDUFA12—bone cancer	0.000177	0.00201	CbGpPWpGaD
Pitavastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000175	0.00198	CbGpPWpGaD
Pitavastatin—Jaundice—Epirubicin—bone cancer	0.000172	0.00797	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.00017	0.00193	CbGpPWpGaD
Pitavastatin—Hepatitis—Methotrexate—bone cancer	0.000169	0.00784	CcSEcCtD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000162	0.00184	CbGpPWpGaD
Pitavastatin—Hypersensitivity—Cisplatin—bone cancer	0.000161	0.00748	CcSEcCtD
Pitavastatin—UGT2B7—Metabolism—NDUFA12—bone cancer	0.00016	0.00181	CbGpPWpGaD
Pitavastatin—Jaundice—Doxorubicin—bone cancer	0.000159	0.00738	CcSEcCtD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000158	0.00179	CbGpPWpGaD
Pitavastatin—Hepatitis—Epirubicin—bone cancer	0.000158	0.00734	CcSEcCtD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000158	0.00179	CbGpPWpGaD
Pitavastatin—Hypoaesthesia—Epirubicin—bone cancer	0.000157	0.0073	CcSEcCtD
Pitavastatin—Asthenia—Cisplatin—bone cancer	0.000157	0.00729	CcSEcCtD
Pitavastatin—UGT1A3—Metabolism—NT5C3A—bone cancer	0.000156	0.00176	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000152	0.00172	CbGpPWpGaD
Pitavastatin—Diarrhoea—Cisplatin—bone cancer	0.00015	0.00695	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—NT5C3A—bone cancer	0.000147	0.00166	CbGpPWpGaD
Pitavastatin—Hepatitis—Doxorubicin—bone cancer	0.000146	0.00679	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—bone cancer	0.000146	0.00676	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—bone cancer	0.000142	0.00661	CcSEcCtD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000141	0.0016	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00014	0.00159	CbGpPWpGaD
Pitavastatin—Rash—Cisplatin—bone cancer	0.000138	0.0064	CcSEcCtD
Pitavastatin—Dermatitis—Cisplatin—bone cancer	0.000138	0.0064	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—bone cancer	0.000137	0.00634	CcSEcCtD
Pitavastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000136	0.00154	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000134	0.00152	CbGpPWpGaD
Pitavastatin—Back pain—Epirubicin—bone cancer	0.000133	0.00618	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—bone cancer	0.000133	0.00616	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—bone cancer	0.000132	0.00614	CcSEcCtD
Pitavastatin—UGT2B7—Metabolism—NT5C3A—bone cancer	0.000132	0.0015	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000131	0.00149	CbGpPWpGaD
Pitavastatin—Nausea—Cisplatin—bone cancer	0.00013	0.00603	CcSEcCtD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00013	0.00147	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Epirubicin—bone cancer	0.000128	0.00593	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—bone cancer	0.000125	0.00581	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—bone cancer	0.000125	0.00581	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—bone cancer	0.000124	0.00576	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—bone cancer	0.000124	0.00574	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—bone cancer	0.000123	0.00572	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—bone cancer	0.000123	0.00569	CcSEcCtD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000122	0.00138	CbGpPWpGaD
Pitavastatin—Confusional state—Methotrexate—bone cancer	0.000121	0.00562	CcSEcCtD
Pitavastatin—SLCO1B1—Metabolism—NDUFA12—bone cancer	0.000119	0.00135	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Doxorubicin—bone cancer	0.000118	0.00549	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—bone cancer	0.000117	0.00544	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—bone cancer	0.000117	0.00544	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—bone cancer	0.000116	0.00538	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—bone cancer	0.000115	0.00533	CcSEcCtD
Pitavastatin—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000114	0.00129	CbGpPWpGaD
Pitavastatin—Confusional state—Epirubicin—bone cancer	0.000113	0.00526	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000113	0.00128	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000112	0.00127	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000112	0.00127	CbGpPWpGaD
Pitavastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000111	0.00125	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00011	0.00125	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NDUFA12—bone cancer	0.00011	0.00125	CbGpPWpGaD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000109	0.00508	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—bone cancer	0.000109	0.00504	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—bone cancer	0.000109	0.00503	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—bone cancer	0.000109	0.00503	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—bone cancer	0.000107	0.00497	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—bone cancer	0.000106	0.00491	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—bone cancer	0.000105	0.00487	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—bone cancer	0.000104	0.00481	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—ENO2—bone cancer	0.000103	0.00116	CbGpPWpGaD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000102	0.00475	CcSEcCtD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000102	0.00116	CbGpPWpGaD
Pitavastatin—Insomnia—Epirubicin—bone cancer	0.000102	0.00472	CcSEcCtD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.0001	0.00114	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Methotrexate—bone cancer	9.9e-05	0.00459	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—bone cancer	9.9e-05	0.00459	CcSEcCtD
Pitavastatin—SLCO1B1—Metabolism—NT5C3A—bone cancer	9.86e-05	0.00112	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Methotrexate—bone cancer	9.82e-05	0.00456	CcSEcCtD
Pitavastatin—CYP2C8—Biological oxidations—GSTP1—bone cancer	9.75e-05	0.00111	CbGpPWpGaD
Pitavastatin—Fatigue—Epirubicin—bone cancer	9.69e-05	0.0045	CcSEcCtD
Pitavastatin—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	9.62e-05	0.00109	CbGpPWpGaD
Pitavastatin—Constipation—Epirubicin—bone cancer	9.61e-05	0.00446	CcSEcCtD
Pitavastatin—Urticaria—Methotrexate—bone cancer	9.54e-05	0.00443	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—DHFR—bone cancer	9.52e-05	0.00108	CbGpPWpGaD
Pitavastatin—Abdominal pain—Methotrexate—bone cancer	9.5e-05	0.00441	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.48e-05	0.0044	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—bone cancer	9.41e-05	0.00436	CcSEcCtD
Pitavastatin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.28e-05	0.00105	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	9.28e-05	0.00105	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Epirubicin—bone cancer	9.27e-05	0.0043	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—bone cancer	9.19e-05	0.00427	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—bone cancer	9.16e-05	0.00425	CcSEcCtD
Pitavastatin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.16e-05	0.00104	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.14e-05	0.00104	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NT5C3A—bone cancer	9.13e-05	0.00103	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.01e-05	0.00102	CbGpPWpGaD
Pitavastatin—Fatigue—Doxorubicin—bone cancer	8.97e-05	0.00416	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—bone cancer	8.93e-05	0.00414	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—GNA11—bone cancer	8.9e-05	0.00101	CbGpPWpGaD
Pitavastatin—Constipation—Doxorubicin—bone cancer	8.9e-05	0.00413	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—bone cancer	8.89e-05	0.00412	CcSEcCtD
Pitavastatin—Hypersensitivity—Methotrexate—bone cancer	8.85e-05	0.00411	CcSEcCtD
Pitavastatin—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.69e-05	0.000985	CbGpPWpGaD
Pitavastatin—Asthenia—Methotrexate—bone cancer	8.62e-05	0.004	CcSEcCtD
Pitavastatin—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	8.59e-05	0.000974	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Doxorubicin—bone cancer	8.57e-05	0.00398	CcSEcCtD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.54e-05	0.000968	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Doxorubicin—bone cancer	8.51e-05	0.00395	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—bone cancer	8.5e-05	0.00394	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—ENO2—bone cancer	8.37e-05	0.000948	CbGpPWpGaD
Pitavastatin—Hypersensitivity—Epirubicin—bone cancer	8.28e-05	0.00384	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—bone cancer	8.26e-05	0.00383	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—bone cancer	8.22e-05	0.00382	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—bone cancer	8.22e-05	0.00381	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—CYP3A4—bone cancer	8.07e-05	0.000914	CbGpPWpGaD
Pitavastatin—Asthenia—Epirubicin—bone cancer	8.07e-05	0.00374	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.03e-05	0.00091	CbGpPWpGaD
Pitavastatin—Pruritus—Epirubicin—bone cancer	7.95e-05	0.00369	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—bone cancer	7.94e-05	0.00369	CcSEcCtD
Pitavastatin—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.94e-05	0.0009	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.83e-05	0.000887	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—DHFR—bone cancer	7.76e-05	0.00088	CbGpPWpGaD
Pitavastatin—Diarrhoea—Epirubicin—bone cancer	7.69e-05	0.00357	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—bone cancer	7.66e-05	0.00356	CcSEcCtD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.64e-05	0.000866	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.62e-05	0.000863	CbGpPWpGaD
Pitavastatin—Rash—Methotrexate—bone cancer	7.58e-05	0.00351	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—bone cancer	7.57e-05	0.00351	CcSEcCtD
Pitavastatin—Headache—Methotrexate—bone cancer	7.53e-05	0.00349	CcSEcCtD
Pitavastatin—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.51e-05	0.000851	CbGpPWpGaD
Pitavastatin—Asthenia—Doxorubicin—bone cancer	7.46e-05	0.00346	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—bone cancer	7.43e-05	0.00345	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—bone cancer	7.36e-05	0.00341	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—GNA11—bone cancer	7.25e-05	0.000822	CbGpPWpGaD
Pitavastatin—Nausea—Methotrexate—bone cancer	7.14e-05	0.00331	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—bone cancer	7.12e-05	0.0033	CcSEcCtD
Pitavastatin—Rash—Epirubicin—bone cancer	7.09e-05	0.00329	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—bone cancer	7.08e-05	0.00329	CcSEcCtD
Pitavastatin—Headache—Epirubicin—bone cancer	7.04e-05	0.00327	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—GSTP1—bone cancer	6.9e-05	0.000782	CbGpPWpGaD
Pitavastatin—Dizziness—Doxorubicin—bone cancer	6.88e-05	0.00319	CcSEcCtD
Pitavastatin—CYP2C8—Metabolism—NDUFA12—bone cancer	6.84e-05	0.000775	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ENO2—bone cancer	6.82e-05	0.000773	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NDUFA12—bone cancer	6.8e-05	0.00077	CbGpPWpGaD
Pitavastatin—Nausea—Epirubicin—bone cancer	6.68e-05	0.0031	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—CYP3A4—bone cancer	6.58e-05	0.000745	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.58e-05	0.000745	CbGpPWpGaD
Pitavastatin—Rash—Doxorubicin—bone cancer	6.56e-05	0.00304	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—bone cancer	6.55e-05	0.00304	CcSEcCtD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.54e-05	0.000742	CbGpPWpGaD
Pitavastatin—Headache—Doxorubicin—bone cancer	6.52e-05	0.00302	CcSEcCtD
Pitavastatin—ALB—Folate Metabolism—TP53—bone cancer	6.44e-05	0.000729	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ENO2—bone cancer	6.43e-05	0.000728	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—DHFR—bone cancer	6.33e-05	0.000717	CbGpPWpGaD
Pitavastatin—Nausea—Doxorubicin—bone cancer	6.18e-05	0.00287	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—DHFR—bone cancer	5.96e-05	0.000676	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NDUFA12—bone cancer	5.96e-05	0.000675	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GNA11—bone cancer	5.91e-05	0.00067	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ENO2—bone cancer	5.8e-05	0.000657	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SPARC—bone cancer	5.77e-05	0.000654	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.66e-05	0.000642	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NT5C3A—bone cancer	5.66e-05	0.000642	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NT5C3A—bone cancer	5.63e-05	0.000638	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSTP1—bone cancer	5.62e-05	0.000638	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GNA11—bone cancer	5.57e-05	0.000632	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NDUFA12—bone cancer	5.56e-05	0.000631	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—DHFR—bone cancer	5.38e-05	0.00061	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP3A4—bone cancer	5.36e-05	0.000608	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—GNA11—bone cancer	5.28e-05	0.000598	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP3A4—bone cancer	5.05e-05	0.000573	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GNA11—bone cancer	5.03e-05	0.00057	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.03e-05	0.00057	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NT5C3A—bone cancer	4.94e-05	0.000559	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL3—bone cancer	4.78e-05	0.000542	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NT5C3A—bone cancer	4.61e-05	0.000523	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTP1—bone cancer	4.59e-05	0.00052	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP3A4—bone cancer	4.56e-05	0.000517	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTP1—bone cancer	4.32e-05	0.00049	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ENO2—bone cancer	4.32e-05	0.000489	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.2e-05	0.000476	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.05e-05	0.000459	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—DHFR—bone cancer	4.01e-05	0.000454	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ENO2—bone cancer	4e-05	0.000453	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTP1—bone cancer	3.9e-05	0.000442	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GNA11—bone cancer	3.74e-05	0.000424	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—DHFR—bone cancer	3.71e-05	0.00042	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.65e-05	0.000414	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—bone cancer	3.57e-05	0.000405	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GNA11—bone cancer	3.47e-05	0.000393	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP3A4—bone cancer	3.39e-05	0.000385	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.38e-05	0.000383	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP3A4—bone cancer	3.14e-05	0.000356	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLAU—bone cancer	3.14e-05	0.000356	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—bone cancer	2.91e-05	0.00033	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTP1—bone cancer	2.9e-05	0.000329	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.87e-05	0.000325	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—bone cancer	2.69e-05	0.000305	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO2—bone cancer	2.48e-05	0.000281	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO2—bone cancer	2.47e-05	0.00028	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.41e-05	0.000273	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—bone cancer	2.38e-05	0.000269	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—DHFR—bone cancer	2.3e-05	0.000261	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—DHFR—bone cancer	2.29e-05	0.000259	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—bone cancer	2.24e-05	0.000254	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO2—bone cancer	2.16e-05	0.000245	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNA11—bone cancer	2.15e-05	0.000244	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNA11—bone cancer	2.14e-05	0.000242	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—bone cancer	2.02e-05	0.000229	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO2—bone cancer	2.02e-05	0.000229	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—DHFR—bone cancer	2.01e-05	0.000227	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP3A4—bone cancer	1.95e-05	0.000221	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.94e-05	0.00022	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP3A4—bone cancer	1.94e-05	0.00022	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.93e-05	0.000219	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNA11—bone cancer	1.87e-05	0.000212	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—DHFR—bone cancer	1.87e-05	0.000212	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNA11—bone cancer	1.75e-05	0.000198	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP3A4—bone cancer	1.7e-05	0.000193	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—bone cancer	1.67e-05	0.000189	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—bone cancer	1.66e-05	0.000188	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.59e-05	0.00018	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.58e-05	0.000179	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—bone cancer	1.5e-05	0.00017	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—bone cancer	1.45e-05	0.000165	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—bone cancer	1.39e-05	0.000158	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—bone cancer	1.36e-05	0.000154	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—bone cancer	1.26e-05	0.000143	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—bone cancer	8.64e-06	9.8e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—bone cancer	8.59e-06	9.74e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—bone cancer	7.53e-06	8.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—bone cancer	7.03e-06	7.97e-05	CbGpPWpGaD
